We are live on
!
Find out more
FBC
Fairfield, Bush & Co Portfolio holdings
AUM
$180M
1-Year Est. Return
39.51%
This Fund
S&P 500
This Quarter
Est. Return
+12.12%
1 Year Est. Return
+39.51%
3 Year Est. Return
+100.99%
5 Year Est. Return
+139.5%
10 Year Est. Return
+536.52%
AUM
$171M
AUM Growth
+$17.5M
(+11%)
Cap. Flow
+$1.12M
Cap. Flow
% of AUM
0.66%
Top 10 Holdings %
Top 10 Hldgs %
36.71%
Holding
532
New
422
Increased
22
Reduced
72
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVO
Novo Nordisk
NVO
|
+$822K |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$542K |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$516K |
| 4 |
ExxonMobil
XOM
|
+$395K |
| 5 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$351K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$1.35M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$972K |
| 3 |
Microsoft
MSFT
|
+$892K |
| 4 |
JPMorgan Chase
JPM
|
+$843K |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$810K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.84% |
| 2 | Healthcare | 14.53% |
| 3 | Consumer Staples | 13.76% |
| 4 | Financials | 8.41% |
| 5 | Consumer Discretionary | 8.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Morgan Stanley
MS
$331B
| $148K | 0.09% |
+1,585
| New | +$127K |
|
127
Markel Group
MKL
$23.3B
| $142K | 0.08% |
+100
| New | +$142K |
|
128
MPLX
MPLX
$59.3B
| $140K | 0.08% |
+3,800
| New | +$137K |
|
129
CRISPR Therapeutics
CRSP
$4.73B
| $136K | 0.08% |
+2,175
| New | +$120K |
|
130
Vanguard Industrials ETF
VIS
$8.1B
| $134K | 0.08% |
+608
| New | +$123K |
|
131
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $132K | 0.08% |
+2,380
| New | +$121K |
|
132
Organon & Co
OGN
$3.56B
| $129K | 0.08% |
8,956
-6,412
| -42% | -$87.2K |
|
133
Vanguard Short-Term Bond ETF
BSV
$44.7B
| $127K | 0.07% |
+1,650
| New | +$125K |
|
134
Wells Fargo
WFC
$261B
| $126K | 0.07% |
+2,556
| New | +$110K |
|
135
Stryker
SYK
$125B
| $123K | 0.07% |
+411
| New | +$115K |
|
136
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $122K | 0.07% |
+3,900
| New | +$117K |
|
137
Abbott
ABT
$183B
| $121K | 0.07% |
+1,103
| New | +$110K |
|
138
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.09B
| $117K | 0.07% |
+3,828
| New | +$117K |
|
139
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| $114K | 0.07% |
+2,835
| New | +$109K |
|
140
Mondelez International
MDLZ
$79.5B
| $110K | 0.06% |
+1,513
| New | +$104K |
|
141
Uber
UBER
$143B
| $109K | 0.06% |
+1,764
| New | +$92.3K |
|
142
Sunrun
RUN
$2.34B
| $108K | 0.06% |
+5,505
| New | +$69.8K |
|
143
Emerson Electric
EMR
$83.9B
| $108K | 0.06% |
+1,107
| New | +$101K |
|
144
iShares Biotechnology ETF
IBB
$9.34B
| $108K | 0.06% |
+793
| New | +$96.8K |
|
145
Lantheus
LNTH
$6.49B
| $107K | 0.06% |
+1,730
| New | +$117K |
|
146
Akamai
AKAM
$16.7B
| $107K | 0.06% |
+905
| New | +$101K |
|
147
T. Rowe Price
TROW
$23.9B
| $107K | 0.06% |
+990
| New | +$98.6K |
|
148
TJX Companies
TJX
$174B
| $106K | 0.06% |
+1,126
| New | +$101K |
|
149
Crown Holdings
CCK
$12.8B
| $105K | 0.06% |
+1,145
| New | +$97.1K |
|
150
Becton Dickinson
BDX
$45.6B
| $105K | 0.06% |
+430
| New | +$106K |
|
Similar funds
KCM
AG
AIC
PCA
HIC
V
RVM
FFA
Fairfield, Bush & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Fairfield, Bush & Co held 532 positions worth $171M, up 11% from $153M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Fairfield, Bush & Co's Q4 2023 filing shows 422 new, 22 increased, 72 reduced and 2 closed positions. Its largest new stake was iShares Russell 2000 ETF: 3,027 shares worth $608K. The largest sale was Seagen Inc. Common Stock, an estimated $1.35M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Staples.
- Fairfield, Bush & Co's largest Q4 2023 buy was iShares Russell 2000 ETF: 3,027 shares worth $608K.
- Fairfield, Bush & Co added most to Novo Nordisk in Q4 2023, an estimated $822K increase.
- Fairfield, Bush & Co's biggest Q4 2023 reduction was Seagen Inc. Common Stock, cutting an estimated $1.35M.
- Fairfield, Bush & Co fully exited Activision Blizzard in Q4 2023, selling an estimated $810K.
- Fairfield, Bush & Co's ten largest holdings make up 37% of its $171M portfolio in Q4 2023.
- Fairfield, Bush & Co opened 422 new positions and closed 2 in Q4 2023.
- Fairfield, Bush & Co's portfolio value rose 11% quarter-over-quarter to $171M.
Based on Fairfield, Bush & Co's 13F filing for Q4 2023, filed 13 Feb 2024.